COVID-19: Manifestações Cutânea (COVID-19: Cutaneous Manifestations)

■ Dermatology and COVID-19

K Shinkai, A L Bruckner

JAMA September 2020

https://jamanetwork.com/journals/jama/fullarticle/2770862

■ Cutaneous manifestations in the contexto of SARS-CoV 2 infection (COVID-19)

J M Carrascosa, V Morillas, I Bielsa, M Munera-Campos

Actas Dermo-Sifiliográficas 2020, vol 111 (9): 734-742

https://www.actasdermo.org/en-cutaneous-manifestations-in-context-sars-cov-2-articulo-S1578219020302754

■ Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature

Gürkan Kaya, Aysin Kaya, Jean-Hilaire Saurat

Dermatopathology (Basel) 2020 Jun; 7(1): 3–16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583593/

■ Melanoma screening days during the coronavírus disease 2019 (COVID-19) pandemic: strategies to adopt

Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi

Dermatol Ther (Heidelb) 2020 Aug; 10(4): 525–527

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255447/

■ Novel coronavírus disease (COVID-19) and biologic therapy for psoriasis: sucessful recovery in two patients after infection with severe acute respiratory syndrome coronavírus 2 (SARS-CoV-2)

Nicholas D. Brownstone, Quinn G. Thibodeaux, Vidhatha D. Reddy et al

Dermatol Ther (Heidelb) 2020 Aug; 10(4): 881–885

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255969/

■ Novel coronavírus disease (COVID-19) and biologic therapy for psoriasis: infection risk and patient counseling in uncertain times

Nicholas D. Brownstone, Quinn G. Thibodeaux, Vidhatha D. Reddy, et al

Dermatol Ther (Heidelb) 2020 Jun; 10(3): 339–349

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160052/

■ Psoriasis, biological drugs and coronavírus disease 2019: real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, et al

Dermatol Reports. 2020 Jun 25; 12(1): 8642

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336268/

■ Unexpected presentation of COVID-19 in a 38-old male patient: a case report

Narges Malih, Ghazal Hajinasrollah, Marjan Zare, Mahboobeh Taheri

Case Rep Dermatol. 2020 May-Aug; 12(2): 124–131

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443664/

■ Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations

Myriam Garduño-Soto, Jose Alberto Choreño-Parra, Jorge Cazarin-Barrientos

Arch Dermatol Res. 2020 Nov 6 : 1–12.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646711/

■ Are the cutaneous manifestationns during or due to SARS-CoV-2 infection/,COVID-19 frequent or not? Revisionn of possible pathophysiologic mechanisms

Paulo Ricardo Criado, Beatrice Martinez Zugaib Abdalla et al

Inflamm Res. 2020 Jun 2 : 1–12

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266387/

■ National Psoriasis Foundation COVID-19 Task Force Guidance for management of psoriatic disease during the pandemic: versionn 1

Joel M. Gelfand, April W. Armstrong, Stacie Bell, et al

J Am Acad Dermatol. 2020 Dec; 83(6): 1704–1716

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471802/

■ COVID-19 pandemic and the skin

Kossara Drenovska, Enno Schmidt, Snejina Vassileva

Int J Dermatol. 2020 Sep 21 : 10.1111/ijd.15189

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537512/

■ A review of the dematological manifestationns of coronarvirus disease 2019 (COVID-19)